Patient Name : Mrs.B.
SUNITHA Collected : 27/Aug/2025 10:23AM
Age/Gender : 40 Y 0 M 0 D /F Received : 27/Aug/2025 11:06AM
UHID/MR No : DMMM.0000002553 Reported : 27/Aug/2025 11:50AM
Visit ID : DMMMOPV3967 Status : Final Report
Ref Doctor : [Link] Client Name : PCC MAMMILAGUDEM
IP/OP NO : Center location : ,Khammam
DEPARTMENT OF HAEMATOLOGY
XPERT HEALTH FEVER ASSESSMENT ADVANCE
Test Name Result Unit Bio. Ref. Interval Method
COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD EDTA
HAEMOGLOBIN 12.0 g/dL 12-15 CYANIDE FREE
COLOUROMETER
PCV 35.00 % 40-50 PULSE HEIGHT AVERAGE
RBC COUNT 4.03 Million/[Link] 3.8-4.8 Electrical Impedence
MCV 87.6 fL 83-101 Calculated
MCH 29.7 pg 27-32 Calculated
MCHC 33.9 g/dL 31.5-34.5 Calculated
R.D.W 11.8 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 4,000 cells/[Link] 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 49 % 40-80 Electrical Impedance
LYMPHOCYTES 47 % 20-40 Electrical Impedance
EOSINOPHILS 01 % 1-6 Electrical Impedance
MONOCYTES 03 % 2-10 Electrical Impedance
BASOPHILS 00 % <1-2 Electrical Impedance
CORRECTED TLC 4,000 Cells/[Link] Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 1960 Cells/[Link] 2000-7000 Calculated
LYMPHOCYTES 1880 Cells/[Link] 1000-3000 Calculated
EOSINOPHILS 40 Cells/[Link] 20-500 Calculated
MONOCYTES 120 Cells/[Link] 200-1000 Calculated
Neutrophil lymphocyte ratio (NLR) 1.04 0.78- 3.53 Calculated
PLATELET COUNT 190000 cells/[Link] 150000-410000 IMPEDENCE/MICROSCOPY
MPV 9.2 Fl 8.1-13.9 Calculated
Page 1 of 3
SIN No:HA09600295
Patient Name : [Link] Collected : 27/Aug/2025 10:23AM
Age/Gender : 40 Y 0 M 0 D /F Received : 27/Aug/2025 11:06AM
UHID/MR No : DMMM.0000002553 Reported : 27/Aug/2025 11:50AM
Visit ID : DMMMOPV3967 Status : Final Report
Ref Doctor : [Link] Client Name : PCC MAMMILAGUDEM
IP/OP NO : Center location : ,Khammam
DEPARTMENT OF HAEMATOLOGY
XPERT HEALTH FEVER ASSESSMENT ADVANCE
Test Name Result Unit Bio. Ref. Interval Method
MALARIA VIVAX ANTIGEN , WHOLE NEGATIVE NEGATIVE Immunochromotography.
BLOOD EDTA
MALARIA FALCIPARUM ANTIGEN , NEGATIVE NEGATIVE Immunochromotography
WHOLE BLOOD EDTA
Comment:
1. The test uses monoclonal anti-pf HRP-2 antibody (for P. Falciparum) and monoclonal anti-pv specific pLDH antibody (P.
vivax)
2. This is only a screening test. The results of the test are to be interpreted within the epidemiological, clinical and therapeutic
context.
3. Since the HRP-2 levels persists for upto 15 days even after successful therapy, a reactive test result does not indicate a
failed therapeutic response.
4. Patient with rheumatoid factor, anti-nuclear antibody or dengue may give false positive results.
Page 2 of 3
SIN No:HA09600295
Patient Name : [Link] Collected : 27/Aug/2025 10:23AM
Age/Gender : 40 Y 0 M 0 D /F Received : 27/Aug/2025 11:08AM
UHID/MR No : DMMM.0000002553 Reported : 27/Aug/2025 12:06PM
Visit ID : DMMMOPV3967 Status : Final Report
Ref Doctor : [Link] Client Name : PCC MAMMILAGUDEM
IP/OP NO : Center location : ,Khammam
DEPARTMENT OF SEROLOGY
XPERT HEALTH FEVER ASSESSMENT ADVANCE
Test Name Result Unit Bio. Ref. Interval Method
WIDAL TEST (SLIDE METHOD)
SALMONELLA TYPHI `O` , SERUM 1:80 SLIDE
AGGLUTINATION
SALMONELLA TYPHI `H` , SERUM 1:80 SLIDE
AGGLUTINATION
[Link] A `H` , SERUM NIL SLIDE
AGGLUTINATION
[Link] B `H` , SERUM NIL SLIDE
AGGLUTINATION
Comment:
• This test measures somatic O and flagellar H antibodies against Typhoid and Paratyphoid bacilli.
• Titres 1:80 and above of “O” antigen & 1:160 and above of “H” antigen for Salmonella typhi and titres 1:80 and above of “H” antigen for Salmonella paratyphi A
& B are significant
• Rising titres in paired samples taken 7-10 days apart are more significant than a single test.
• Reactive results indicates ongoing or recent infection by Salmonella spp. and the diagnosis should be confirmed by gold standard test such as Blood culture prior
to start of antibiotics.
• The reactivity will vary with stage of the disease with appearance in 1st week to increase in titres till end of 4th week post which it starts decreasing.
• A positive Widal test may occur because of typhoid vaccination or previous typhoid infection and in certain autoimmune diseases. Non-specific febrile disease
may cause this titer to increase.
• A positive Widal test may occur because of typhoid vaccination or previous typhoid infection and in certain autoimmune diseases. Non-specific febrile disease
may cause this titer to increase.
• The recommended test especially in the first week after infection is Blood Culture.
Note:
1. This report is issued after performing Slide agglutination method.
2. If positive titres, the result is to be confirmed by Tube agglutination method.
*** End Of Report ***
Result/s to Follow:
C-REACTIVE PROTEIN (CRP) - QUANTITATIVE, COMPLETE URINE EXAMINATION (CUE), DENGUE NS1 ANTIGEN, DENGUE IGG & IGM,
TYPHIDOT IgM, ERYTHROCYTE SEDIMENTATION RATE (ESR)
Page 3 of 3
SIN No:SE02856549
Patient Name : [Link] Collected : 27/Aug/2025 10:23AM
Age/Gender : 40 Y 0 M 0 D /F Received : 27/Aug/2025 11:08AM
UHID/MR No : DMMM.0000002553 Reported : 27/Aug/2025 12:06PM
Visit ID : DMMMOPV3967 Status : Final Report
Ref Doctor : [Link] Client Name : PCC MAMMILAGUDEM
IP/OP NO : Center location : ,Khammam
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals, who understand
reporting units, reference ranges and limitation of technologies. Laboratories not be responsible for any interpretation whatsoever
2. This is computer generated medical diagnostics report that has been validated by an Authorized Medical Practitioner/Doctor. The
report does not need physical signature.
3. Partial reproduction of this report is not valid and should not be resorted to draw any conclusion.
4. In the case you are not the intended recipient of this report. Please immediately return the same to the concerned issuing desk. Any
disclosure, copy or distribution of any contents of this report, is unlawful and is strictly prohibited.
5. Results delays may occur due to unforeseen circumstances such as non-availability of kits, equipment breakdown, natural calamities,
IT downtime, logistic delays or any other unavoidable event. For certain tests based on analyte stability, criticality of results and in the
interest of patient for having appropriate medical diagnosis, the same test may be outsourced to other accredited laboratory.
6. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the verifications of
particulars have been confirmed by the patient or his / her representative at the point of generation of said specimen
7. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
8. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies
9. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
10. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only
SIN No:SE02856549
